CLASS II Drug recall · Reported 8 Aug 2012 · FDA Enforcement Report

Fosphenytoin Sodium Injection, USP, 100 mg PE recalled

West-ward Pharmaceutical is recalling Fosphenytoin Sodium Injection, USP, 100 mg PE per (50 mg PE per mL) Single Dose Vial, distributed nationwide in the US. The recall was initiated on 13 Apr 2012 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #s: a) 113153.1, 113154.1, 113155.1, Exp 05/13; 113248.1, Exp 07/13; b) 103196.1, 103197.1, 103197.2, 103198.1, Exp 07/12; 103317.1, 103318.1, 103319.1, 103345.1, 103345.2, Exp 11/12; 103346.1, 103347.1, 103348.1, 103349.1, 103350.1, Exp 12/12; 113030.1, 113031.1, 113032.1, 113033.1, 113034.1, 113035.1, 113036.1, Exp 01/13; 113245.1, 113246.1, 113247.1, Exp 07/13
NDC0143-9782, 0143-9788
Quantity recalleda) 308,275 vials; b) 2,008,850 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1437-2012
FDA event ID
62627
Recalling firm
West-ward Pharmaceutical, Eatontown, NJ
Manufacturer
West-Ward Pharmaceuticals Corp
Classification
Class II
Status
Terminated
Recall initiated
13 Apr 2012
FDA classified
2 Aug 2012
Reported
8 Aug 2012
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

13 Apr 2012Recall initiated by company
2 Aug 2012Classified by FDA+111 days
8 Aug 2012Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples.

Product as listed by the FDA

Fosphenytoin Sodium Injection, USP, 100 mg PE per 2 mL (50 mg PE per mL), 2 mL Single Dose Vial, packaged in 25-count x 2 mL Single Dose Vials per carton, Rx only, Mfd. By: Hikma Farmaceutica (Portugal), S.A.; Dist. By: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724 USA under the labels a) NOVAPLUS (NDC 0143-9704-25), b) West-Ward (NDC 0143-9788-25).

Where it was distributed

All lots were distributed throughout the US.

Nationwide

Questions about this recall

Why was it recalled?

Presence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples.

Which lots are affected?

Lot #s: a) 113153.1, 113154.1, 113155.1, Exp 05/13; 113248.1, Exp 07/13; b) 103196.1, 103197.1, 103197.2, 103198.1, Exp 07/12; 103317.1, 103318.1, 103319.1, 103345.1, 103345.2, Exp 11/12; 103346.1, 103347.1, 103348.1, 103349.1, 103350.1, Exp 12/12; 113030.1, 113031.1, 113032.1, 113033.1, 113034.1, 113035.1, 113036.1, Exp 01/13; 113245.1, 113246.1, 113247.1, Exp 07/13

Where was it sold?

All lots were distributed throughout the US.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 62627

This product is part of a recall event; the main page for the event is Fosphenytoin Sodium Injection, USP, 500 mg PE recalled.

ReportedClassRecallCompanyReasonWhere
CLASS IIFosphenytoin Sodium Injection, USP, 500 mg PE recalledFosphenytoin SodiumWest-ward PharmaceuticalParticulate MatterNationwide

More recalls from West-ward Pharmaceutical

All 30

Other Fosphenytoin recalls

All 6